Application 062031
- Type
- ANDA
- Sponsor
- ACTAVIS LABS FL INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | CAPSULE;ORAL | EQ 100MG BASE | No | No |
| 002 | DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | CAPSULE;ORAL | EQ 50MG BASE | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0591-5440 | Doxycycline Hyclate | Doxycycline Hyclate | Actavis Pharma, Inc. | ANDA | Current |
| 0591-5440 | Doxycycline Hyclate | Doxycycline Hyclate | Actavis Pharma, Inc. | ANDA | Current |
| 0591-5440 | Doxycycline Hyclate | Doxycycline Hyclate | Actavis Pharma, Inc. | ANDA | Current |
| 0591-5535 | Doxycycline Hyclate | Doxycycline Hyclate | Actavis Pharma, Inc. | ANDA | Current |
| 0591-5535 | Doxycycline Hyclate | Doxycycline Hyclate | Actavis Pharma, Inc. | ANDA | Current |
| 0591-5535 | Doxycycline Hyclate | Doxycycline Hyclate | Actavis Pharma, Inc. | ANDA | Current |
| 33261-899 | Doxycycline Hyclate | Doxycycline Hyclate | Aidarex Pharmaceuticals LLC | ANDA | Current |
| 51655-184 | Doxycycline Hyclate | Doxycycline Hyclate | Northwind Pharmaceuticals | ANDA | Current |
| 53808-0962 | Doxycycline Hyclate | Doxycycline Hyclate | State of Florida DOH Central Pharmacy | ANDA | Current |
| 55154-2650 | Doxycycline Hyclate | Doxycycline Hyclate | Cardinal Health | ANDA | Current |
| 60687-118 | Doxycycline Hyclate | Doxycycline Hyclate | American Health Packaging | ANDA | Current |
| 60687-118 | Doxycycline Hyclate | Doxycycline Hyclate | American Health Packaging | ANDA | Current |
| 60687-118 | Doxycycline Hyclate | Doxycycline Hyclate | American Health Packaging | ANDA | Current |
| 64725-5440 | Doxycycline Hyclate | Doxycycline Hyclate | TYA Pharmaceuticals | ANDA | Current |
| 71335-0635 | Doxycycline Hyclate | Doxycycline Hyclate | Bryant Ranch Prepack | ANDA | Current |